Last update :
28/04/2024
References   References 1955  
Type : Journal
Web link : https://doi.org/10.1345/aph.1E408

Research teams : Houston - M.D.Anderson Cancer Center
Authors : Trissel LA, Zhang Y.
Title : Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Reference : Ann Pharmacotherapy ; 39: 280-283. 2005

Level of Evidence : 
Level of evidence A+
Physical stability : 
Visual examination Turbidimetry Particle counting 
Chemical stability : 
High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)
Stability defined as 95% of the initial concentration
Other methods : 
Comments : 
Degradation products not observed in real conditions

List of drugs
InjectionDoxorubicin hydrochloride Anticancer drug
Compatible 1 mg/ml + InjectionPalonosetron hydrochloride 50 µg/ml + Glucose 5%
InjectionEpirubicin hydrochloride Anticancer drug
Compatible 0,5 mg/ml + InjectionPalonosetron hydrochloride 50 µg/ml + Glucose 5%
InjectionPalonosetron hydrochloride Antiemetic
Compatible 50 µg/ml + InjectionDoxorubicin hydrochloride 1 mg/ml + Glucose 5%
Compatible 50 µg/ml + InjectionEpirubicin hydrochloride 0,5 mg/ml + Glucose 5%
Stability of mixtures
Glass Glucose 5% 23°C Not specified
Injection Palonosetron hydrochloride 25 µg/ml
Injection Doxorubicin hydrochloride 0,1 mg/ml
4 Hour
Glass Glucose 5% 23°C Not specified
Injection Palonosetron hydrochloride 26 µg/ml
Injection Epirubicin hydrochloride 0,26 mg/ml
4 Hour

  Mentions Légales